Lucrecia Carrera Quintanar

Dr. Lucrecia Carrera Quintanar

Universidad de Guadalajara, Guadalajara, Jalisco, Mexico
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
RARodrigo Arreola
Rodrigo Arreola
SQSaray Saray Quintero Quintero
Saray Saray Quintero Quintero
RRRocio Ivette Lopez Roa
Rocio Ivette Lopez Roa
EFEnrique Octavio Flores-Gutiérrez
Enrique Octavio Flores-Gutiérrez
JRJuan Pablo Reyes-Grajeda
Juan Pablo Reyes-Grajeda
Daniel Ortuño-SahagúnDaniel Ortuño-Sahagún
Daniel Ortuño-Sahagún
The benefits of garlic to health have been proclaimed for centuries; however, only recently haveAllium sativumand its derivatives been proposed as promising candidates for maintaining the homeostasis of the immune system. The complex biochemistry of garlic makes it possible for variations in processing to yield different preparations with differences in final composition and compound proportion. In this review, we assess the most recent experimental results, which indicate that garlic appears to enhance the functioning of the immune system by stimulating certain cell types, such as macrophages, lymphocytes, natural killer (NK) cells, dendritic cells, and eosinophils, by mechanisms including modulation of cytokine secretion, immunoglobulin production, phagocytosis, and macrophage activation. Finally, because immune dysfunction plays an important role in the development and progress of several diseases, we critically examined immunoregulation by garlic extracts and compounds isolated, which can contribute to the treatment and prevention of pathologies such as obesity, metabolic syndrome, cardiovascular disorders, gastric ulcer, and even cancer. We concluded thatA. sativummodulates cytokine secretion and that such modulation may provide a mechanism of action for many of their therapeutic effects.

2 December 2011 in Cell Death & Differentiation
Verified
Journal Article
Closed access
JEJ C Estrada
J C Estrada
CAC Albo
C Albo
ABA Benguría
A Benguría
ADA Dopazo
A Dopazo
PLP López-Romero
P López-Romero
ESE Samper
E Samper

27 June 2013 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
JEJ C Estrada
J C Estrada
YTY Torres
Y Torres
ABA Benguría
A Benguría
ADA Dopazo
A Dopazo
Enrique  RocheEnrique  Roche
Enrique  Roche
ABA Bernad
A Bernad
In most clinical trials, human mesenchymal stem cells (hMSCs) are expanded in vitro before implantation. The genetic stability of human stem cells is critical for their clinical use. However, the relationship between stem-cell expansion and genetic stability is poorly understood. Here, we demonstrate that within the normal expansion period, hMSC cultures show a high percentage of aneuploid cells that progressively increases until senescence. Despite this accumulation, we show that in a heterogeneous culture the senescence-prone hMSC subpopulation has a lower proliferation potential and a higher incidence of aneuploidy than the non-senescent subpopulation. We further show that senescence is linked to a novel transcriptional signature that includes a set of genes implicated in ploidy control. Overexpression of the telomerase catalytic subunit (human telomerase reverse transcriptase, hTERT) inhibited senescence, markedly reducing the levels of aneuploidy and preventing the dysregulation of ploidy-controlling genes. hMSC-replicative senescence was accompanied by an increase in oxygen consumption rate (OCR) and oxidative stress, but in long-term cultures that overexpress hTERT, these parameters were maintained at basal levels, comparable to unmodified hMSCs at initial passages. We therefore propose that hTERT contributes to genetic stability through its classical telomere maintenance function and also by reducing the levels of oxidative stress, possibly, by controlling mitochondrial physiology. Finally, we propose that aneuploidy is a relevant factor in the induction of senescence and should be assessed in hMSCs before their clinical use.

1 January 2018 in Mediators of Inflammation
Verified
Journal Article
Open access
LQLucrecia Carrera Quintanar
Lucrecia Carrera Quintanar
RRRocio Ivette Lopez Roa
Rocio Ivette Lopez Roa
SQSaray Saray Quintero Quintero
Saray Saray Quintero Quintero
ASAlma Marina Sánchez Sánchez
Alma Marina Sánchez Sánchez
Barbara VizmanosBarbara Vizmanos
Barbara Vizmanos
Daniel Ortuño-SahagúnDaniel Ortuño-Sahagún
Daniel Ortuño-Sahagún
Gut microbiota (GM) plays several crucial roles in host physiology and influences several relevant functions. In more than one respect, it can be said that you “feed your microbiota and are fed by it.” GM diversity is affected by diet and influences metabolic and immune functions of the host’s physiology. Consequently, an imbalance of GM, or dysbiosis, may be the cause or at least may lead to the progression of various pathologies such as infectious diseases, gastrointestinal cancers, inflammatory bowel disease, and even obesity and diabetes. Therefore, GM is an appropriate target for nutritional interventions to improve health. For this reason, phytochemicals that can influence GM have recently been studied as adjuvants for the treatment of obesity and inflammatory diseases. Phytochemicals include prebiotics and probiotics, as well as several chemical compounds such as polyphenols and derivatives, carotenoids, and thiosulfates. The largest group of these comprises polyphenols, which can be subclassified into four main groups: flavonoids (including eight subgroups), phenolic acids (such as curcumin), stilbenoids (such as resveratrol), and lignans. Consequently, in this review, we will present, organize, and discuss the most recent evidence indicating a relationship between the effects of different phytochemicals on GM that affect obesity and/or inflammation, focusing on the effect of approximately 40 different phytochemical compounds that have been chemically identified and that constitute some natural reservoir, such as potential prophylactics, as candidates for the treatment of obesity and inflammatory diseases.

1 January 2016 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
JGJosé de Jesús Guerrero-García
José de Jesús Guerrero-García
LQLucrecia Carrera Quintanar
Lucrecia Carrera Quintanar
RRRocio Ivette Lopez Roa
Rocio Ivette Lopez Roa
AMAna Laura Márquez-Aguirre
Ana Laura Márquez-Aguirre
ARArgelia Esperanza Rojas-Mayorquín
Argelia Esperanza Rojas-Mayorquín
Daniel Ortuño-SahagúnDaniel Ortuño-Sahagún
Daniel Ortuño-Sahagún
Multiple Sclerosis (MS) is an autoimmune disorder of the Central Nervous System that has been associated with several environmental factors, such as diet and obesity. The possible link between MS and obesity has become more interesting in recent years since the discovery of the remarkable properties of adipose tissue. Once MS is initiated, obesity can contribute to increased disease severity by negatively influencing disease progress and treatment response, but, also, obesity in early life is highly relevant as a susceptibility factor and causally related risk for late MS development. The aim of this review was to discuss recent evidence about the link between obesity, as a chronic inflammatory state, and the pathogenesis of MS as a chronic autoimmune and inflammatory disease. First, we describe the main cells involved in MS pathogenesis, both from neural tissue and from the immune system, and including a new participant, the adipocyte, focusing on their roles in MS. Second, we concentrate on the role of several adipokines that are able to participate in the mediation of the immune response in MS and on the possible cross talk between the latter. Finally, we explore recent therapy that involves the transplantation of adipocyte precursor cells for the treatment of MS.

22 October 2010 in European Journal of Applied Physiology
Verified
Journal Article
Closed access
PDF file
LFLorena Funes
Lorena Funes
LQLucrecia Carrera Quintanar
Lucrecia Carrera Quintanar
MCManuela Cerdán-Calero
Manuela Cerdán-Calero
Miguel D. FerrerMiguel D. Ferrer
Miguel D. Ferrer
FDFranchek Drobnic
Franchek Drobnic
Vicente MicolVicente Micol
Vicente Micol